Assessing compliance within B. Braun in relation to the industry codes

Abstract

This exploratory study aimed to understand the nature of regulatory compliance within B. Braun focuses on the perceptions and experiences of its marketing and sales staff and highlights areas for improvement. B. Braun's multifaceted healthcare offerings navigate a complex regulatory landscape, made more challenging by the diverse regulatory codes they must adhere to. This research addresses a gap in the literature, emphasising the alignment of corporate culture with compliance in the dynamic healthcare industry, especially in the UK. Through a combination of descriptive and thematic analyses, this study utilised qualitative methods, capturing insights from marketing and sales staff about their experiences with regulatory codes and the company's code of conduct. Findings indicated commendable awareness and alignment with B. Braun's code of conduct among employees. However, particular areas, notably targeted marketing, warrant strategic refinement. There is a clear emphasis on the need for consistent and tailored training, given the changing regulatory landscape. Moreover, B. Braun's dedication to transparency and adherence sets a standard in the industry. The study emphasises the importance of a responsive strategy, including regulatory adaptability, technology adoption, partnerships, and ethics. While the company's adherence to ethical standards is noteworthy, there's room for improvement, particularly in training for both teams' compliance. This research offers a unique perspective, clarifying the UK healthcare regulatory dynamics and providing practical insights. For stakeholders, it underscores the advantages of a robust compliance culture, highlighting the need for proactive measures in areas like training. Addressing these would benefit B. Braun's internal operations in light of the relevant codes and reinforce its market position, reflecting broader industry challenges.